Contribute Try STAT+ Today

Good morning, folks. How are you today? Once again, sunny skies and a cool breeze are enveloping the Pharmalot campus, which is a rather quiet place right now, other than the familiar whistle of the coffee kettle on the stove. Our short person is quietly snoozing and the official mascot is napping. We would join them but, alas, there is much to be done. Most likely, you know the feeling. So here are some tidbits to get you started. Hope all goes well today and you conquer the world. …

The European Commission said on Thursday it had reached a temporary agreement with South Africa to use a plant there to bottle Johnson & Johnson (JNJ) Covid-19 vaccines that are being imported into the European Union, Reuters reports. On Wednesday, the World Health Organization Director-General Tedros Adhanom Ghebreyesus said he was “stunned” by news J&J vaccines were being exported from South Africa to the EU, because the EU has very high vaccination rates but in many African countries, not even the most vulnerable are vaccinated.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment